---
title: "XWELL | 10-K: FY2025 Revenue: USD 29.21 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281391343.md"
datetime: "2026-04-01T15:04:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281391343.md)
  - [en](https://longbridge.com/en/news/281391343.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281391343.md)
---

# XWELL | 10-K: FY2025 Revenue: USD 29.21 M

Revenue: As of FY2025, the actual value is USD 29.21 M.

EPS: As of FY2025, the actual value is USD -5.08.

EBIT: As of FY2025, the actual value is USD -16.33 M.

#### Segment Revenue

-   **Total Revenue, Net**
    -   For the year ended December 31, 2025, total revenue was $29,210, a decrease of $4,687 or 14% compared to $33,897 for the year ended December 31, 2024. This decrease was primarily due to a decline in the XpresTest segment, partially offset by growth in Naples Wax locations.
-   **Revenue by Segment (2025)**
    -   XpresSpa: $18,649
    -   XpresTest: $8,249
    -   Naples Wax Center: $2,312
    -   Corporate and other: $0
-   **Revenue by Segment (2024)**
    -   XpresSpa: $18,765
    -   XpresTest: $13,055
    -   Naples Wax Center: $2,077
    -   Corporate and other: $0

#### Operational Metrics

-   **Gross Profit**
    -   For the year ended December 31, 2025, gross profit was $7,506, compared to $8,919 for the year ended December 31, 2024.
-   **Operating Loss/Income by Segment (2025)**
    -   XpresSpa: - $40
    -   XpresTest: $4,314
    -   Naples Wax Center: - $5,845
    -   Corporate and other: - $14,099
-   **Operating Loss/Income by Segment (2024)**
    -   XpresSpa: - $12,301
    -   XpresTest: $5,192
    -   Naples Wax Center: - $496
    -   Corporate and other: - $9,102
-   **Total Operating Loss**
    -   For the year ended December 31, 2025, total operating loss was - $15,670, compared to - $16,707 for the year ended December 31, 2024.
-   **Cost of Sales**
    -   For the year ended December 31, 2025, total cost of sales was $21,704, a decrease of $3,274 or 13% compared to $24,978 for the year ended December 31, 2024, primarily due to the closure of the Treat business and three underperforming XpresSpa locations.
    -   **Labor Costs (2025):** $15,337 total; XpresSpa: $9,250; XpresTest: $4,682; Naples Wax: $1,405.
    -   **Labor Costs (2024):** $17,477 total; XpresSpa: $10,039; XpresTest: $6,148; Naples Wax: $1,258.
    -   **Occupancy Costs (2025):** $3,625 total; XpresSpa: $2,738; XpresTest: $51; Naples Wax: $836.
    -   **Occupancy Costs (2024):** $3,712 total; XpresSpa: $3,417; XpresTest: $35; Naples Wax: $260.
-   **General and Administrative Expenses**
    -   For the year ended December 31, 2025, general and administrative expenses decreased by $4,082 or 20% to $16,000, compared to $20,082 for the year ended December 31, 2024, mainly due to rightsizing and cost optimization.
-   **Depreciation and Amortization**
    -   For the year ended December 31, 2025, depreciation and amortization expense decreased by $76 or 8% to $862, compared to $938 for the year ended December 31, 2024, primarily due to fewer long-lived assets.
    -   **Depreciation and Amortization by Segment (2025):** XpresSpa: $481; XpresTest: $8; Naples Wax: $308; Corporate and other: $65.
    -   **Depreciation and Amortization by Segment (2024):** XpresSpa: $672; XpresTest: $74; Naples Wax: $136; Corporate and other: $56.
-   **Impairment and Loss on Disposal of Assets**
    -   **Impairment of long-lived assets:** $3,149 in 2025 (XpresSpa: $959; Naples Wax: $2,190) compared to $1,711 in 2024.
    -   **Impairment of operating lease right-of-use assets:** $1,736 in 2025 (XpresSpa: $673; Naples Wax: $1,063) compared to $2,805 in 2024.
    -   **Goodwill impairment:** $1,389 in 2025 (related to Naples Wax business) compared to $0 in 2024.
    -   **Loss on disposal of assets, net:** $40 in 2025 compared to $90 in 2024.
-   **Net Loss Attributable to XWELL, Inc.**
    -   For the year ended December 31, 2025, net loss attributable to XWELL, Inc. was - $16,991, compared to - $16,853 for the year ended December 31, 2024.

#### Cash Flow

-   **Net Cash Used in Operating Activities**
    -   For the year ended December 31, 2025, net cash used in operating activities was - $8,713, compared to - $11,005 for the year ended December 31, 2024, primarily due to reduced operating and overhead expenses.
-   **Net Cash Provided by Investing Activities**
    -   For the year ended December 31, 2025, net cash provided by investing activities was $4,332, compared to $5,895 for the year ended December 31, 2024.
-   **Net Cash Provided by Financing Activities**
    -   For the year ended December 31, 2025, net cash provided by financing activities was $1,942, compared to $1,359 for the year ended December 31, 2024.

#### Unique Metrics

-   **XpresTest Bio-surveillance Program Revenue:**
    -   For the year ended December 31, 2025, revenue recognized from the CDC program was $6,984, compared to $11,123 for the year ended December 31, 2024.
    -   The program was extended in February 2025 through a three-year contract with a total base value of $22,200 and a maximum ceiling value of $24,800.
-   **Capital Expenditures by Segment (2025):**
    -   XpresSpa: $1,780
    -   XpresTest: $0
    -   Naples Wax: $932
    -   Corporate and other: $147
    -   Total: $2,859
-   **Capital Expenditures by Segment (2024):**
    -   XpresSpa: $755
    -   XpresTest: $49
    -   Naples Wax: $959
    -   Corporate and other: $18
    -   Total: $1,781
-   **Stock-based Compensation by Segment (2025):**
    -   XpresSpa: $176
    -   XpresTest: $3
    -   Naples Wax: $0
    -   Corporate and other: $903
    -   Total: $1,082
-   **Stock-based Compensation by Segment (2024):**
    -   XpresSpa: $799
    -   XpresTest: $94
    -   Naples Wax: $0
    -   Corporate and other: $0
    -   Total: $893

#### Outlook / Guidance

XWELL, Inc. aims to expand and integrate offerings across its brands, unifying airport and off-airport locations under the XWELL brand to develop membership programs and enhance brand loyalty. The company plans to optimize its airport portfolio for profitability and pursue off-airport growth through acquisitions, particularly in the med spa sector, while expanding bio-security services internationally through partnerships. These strategic efforts are intended to drive sustainable financial and operational growth and maximize shareholder value.

### Related Stocks

- [XWEL.US](https://longbridge.com/en/quote/XWEL.US.md)

## Related News & Research

- [The Limits of Limit Orders in Retail FX/CFD Trading](https://longbridge.com/en/news/287126072.md)
- [Examining options for FX hedging](https://longbridge.com/en/news/286789264.md)
- [Bristow Spotlights Advanced Air Mobility Milestones and Safety Performance in 2025 Sustainability Report | VTOL Stock News](https://longbridge.com/en/news/286912514.md)
- [How to Read the COT Report to Track Forex Market Sentiment](https://longbridge.com/en/news/286848676.md)
- [Birkenstock Earnings Call Highlights Robust Growth Amid FX Headwinds](https://longbridge.com/en/news/286340790.md)